Skip to main content
Journal of Hematology & Oncology logoLink to Journal of Hematology & Oncology
. 2021 Sep 23;14:150. doi: 10.1186/s13045-021-01154-7

Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy

Chunmeng Wang 1,#, Fengxia Shi 1,#, Yang Liu 1, Yajing Zhang 1, Liang Dong 1, Xiang Li 1, Chuan Tong 1, Yao Wang 1, Liping Su 2, Jing Nie 1,✉,#, Weidong Han 1,✉,#
PMCID: PMC8461995  PMID: 34556168

Correction to: J Hematol Oncol (2021) 14:106 10.1186/s13045-021-01120-3

The original article [1] contained a minor error in the Additional file which has since been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jing Nie and Weidong Han jointly supervise this work

Chunmeng Wang and Fengxia Shi are co-first author

Contributor Information

Jing Nie, Email: nnjj2002@163.com.

Weidong Han, Email: hanwdrsw69@yahoo.com.

Reference

  • 1.Wang C, et al. Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy. J Hematol Oncol. 2021;14:106. doi: 10.1186/s13045-021-01120-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Hematology & Oncology are provided here courtesy of BMC

RESOURCES